SanBio Company Limited provided consolidated earnings guidance for the first half of fiscal year ending January 31, 2024, and full fiscal year ending January 31, 2024. For the first half period, the company expects to report operating loss of JPY 2,398 million, ordinary loss of JPY 2,341 million, net loss attributable to the owners of parent of JPY 2,344 million, and net loss per share of JPY 36.85.

For the full year period, the company expects to report operating loss of JPY 4,642 million, ordinary loss of JPY 4,597 million, net loss attributable to the owners of parent of JPY 4,598 million, and net loss per share of JPY 72.30.